Literature DB >> 23993743

FANCD2 binds MCM proteins and controls replisome function upon activation of s phase checkpoint signaling.

Gérald Lossaint1, Marion Larroque, Cyril Ribeyre, Nicole Bec, Christian Larroque, Chantal Décaillet, Kerstin Gari, Angelos Constantinou.   

Abstract

Proteins disabled in Fanconi anemia (FA) are necessary for the maintenance of genome stability during cell proliferation. Upon replication stress signaling by ATR, the FA core complex monoubiquitinates FANCD2 and FANCI in order to activate DNA repair. Here, we identified FANCD2 and FANCI in a proteomic screen of replisome-associated factors bound to nascent DNA in response to replication arrest. We found that FANCD2 can interact directly with minichromosome maintenance (MCM) proteins. ATR signaling promoted the transient association of endogenous FANCD2 with the MCM2-MCM7 replicative helicase independently of FANCD2 monoubiquitination. FANCD2 was necessary for human primary cells to restrain DNA synthesis in the presence of a reduced pool of nucleotides and prevented the accumulation of single-stranded DNA, the induction of p21, and the entry of cells into senescence. These data reveal that FANCD2 is an effector of ATR signaling implicated in a general replisome surveillance mechanism that is necessary for sustaining cell proliferation and attenuating carcinogenesis.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23993743     DOI: 10.1016/j.molcel.2013.07.023

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  111 in total

1.  Hypoxic stress facilitates acute activation and chronic downregulation of fanconi anemia proteins.

Authors:  Susan E Scanlon; Peter M Glazer
Journal:  Mol Cancer Res       Date:  2014-03-31       Impact factor: 5.852

2.  Replication Protein A (RPA) deficiency activates the Fanconi anemia DNA repair pathway.

Authors:  Seok-Won Jang; Jin Ki Jung; Jung Min Kim
Journal:  Cell Cycle       Date:  2016-07-11       Impact factor: 4.534

3.  Proliferation of Double-Strand Break-Resistant Polyploid Cells Requires Drosophila FANCD2.

Authors:  Heidi S Bretscher; Donald T Fox
Journal:  Dev Cell       Date:  2016-06-06       Impact factor: 12.270

Review 4.  The Fanconi anemia ID2 complex: dueling saxes at the crossroads.

Authors:  Rebecca A Boisvert; Niall G Howlett
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

5.  ATR-mediated phosphorylation of FANCI regulates dormant origin firing in response to replication stress.

Authors:  Yu-Hung Chen; Mathew J K Jones; Yandong Yin; Sarah B Crist; Luca Colnaghi; Robert J Sims; Eli Rothenberg; Prasad V Jallepalli; Tony T Huang
Journal:  Mol Cell       Date:  2015-04-02       Impact factor: 17.970

6.  Acute hydroxyurea-induced replication blockade results in replisome components disengagement from nascent DNA without causing fork collapse.

Authors:  Amaia Ercilla; Sonia Feu; Sergi Aranda; Alba Llopis; Sólveig Hlín Brynjólfsdóttir; Claus Storgaard Sørensen; Luis Ignacio Toledo; Neus Agell
Journal:  Cell Mol Life Sci       Date:  2019-07-11       Impact factor: 9.261

Review 7.  The impact of replication stress on replication dynamics and DNA damage in vertebrate cells.

Authors:  Hervé Técher; Stéphane Koundrioukoff; Alain Nicolas; Michelle Debatisse
Journal:  Nat Rev Genet       Date:  2017-07-17       Impact factor: 53.242

8.  Preventing over-resection by DNA2 helicase/nuclease suppresses repair defects in Fanconi anemia cells.

Authors:  Kenneth K Karanja; Eu Han Lee; Eric A Hendrickson; Judith L Campbell
Journal:  Cell Cycle       Date:  2014-03-12       Impact factor: 4.534

9.  CtIP mediates replication fork recovery in a FANCD2-regulated manner.

Authors:  Jung Eun Yeo; Eu Han Lee; Eric A Hendrickson; Alexandra Sobeck
Journal:  Hum Mol Genet       Date:  2014-02-20       Impact factor: 6.150

Review 10.  Fanconi anaemia and cancer: an intricate relationship.

Authors:  Grzegorz Nalepa; D Wade Clapp
Journal:  Nat Rev Cancer       Date:  2018-01-29       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.